Incidence, severity, and associated risk factors for amyloid-related imaging abnormalities in anti-amyloid monoclonal antibody therapy for early Alzheimer's disease: a systematic review and meta-analysis.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansAlzheimer DiseaseAmyloid beta-PeptidesAntibodies, MonoclonalIncidenceRisk FactorsAlzheimer diseaseAmyloid-related imaging abnormalitiesImmunotherapyMeta-analysisRisk factors
Come citare questo studio
Markus A Martinez Holst, Ana Maria Sierra Valiente, Carlos A Garcia-Becerra. (2026). Incidence, severity, and associated risk factors for amyloid-related imaging abnormalities in anti-amyloid monoclonal antibody therapy for early Alzheimer's disease: a systematic review and meta-analysis.. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. DOI: 10.1007/s10072-026-09430-5
Consulta la pubblicazione originale ↗